Cargando…
Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma
Pancreatic cancer is the fourth leading cause of death from cancer in both men and women. Pancreatic cancer is typically diagnosed at an advanced stage and has an overall 5-year survival of approximately 9.3%. The National Comprehensive Cancer Network recommends both germline testing (testing cells...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299794/ https://www.ncbi.nlm.nih.gov/pubmed/34430059 http://dx.doi.org/10.6004/jadpro.2021.12.5.4 |